A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
Abroad (travel likely)RecruitingPHASE2
Conditions
Neuroblastoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study leads
Brian Kushner, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center